SCHEMBL92302

SCHEMBL92302

C=Cc1ccc(C(=O)OCOC2CCCc3ccccc32)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.55
TAS1R1 Q7RTX1 1/20 0.55
IDO1 P14902 2/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 4/20 0.39
POLB P06746 3/20 0.39
HTT P42858 2/20 0.39
GPR84 Q9NQS5 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HAO1 Q9UJM8 1/20 0.37
FFAR1 O14842 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
LMNA P02545 1/20 0.37
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91649 0.90 TAS1R3 (0.47) TAS1R3TAS1R1IDO1KMT2AMEN1
SCHEMBL2192882 0.81 TAS1R3 (0.56) TAS1R3TAS1R1IDO1KMT2AMEN1
SCHEMBL91648 0.78 IDO1 (0.38) TAS1R3TAS1R1IDO1KMT2AMEN1
SCHEMBL71690 0.77 TAS1R3 (0.39) TAS1R3TAS1R1IDO1KMT2AMEN1
SCHEMBL92270 0.75 IDO1 (0.47) TAS1R3TAS1R1IDO1KMT2AMEN1
SCHEMBL11999054 0.73 IDO1 (0.53) TAS1R3TAS1R1IDO1ALDH1A1GPR84
SCHEMBL26810445 0.72 SNCA (0.49) TAS1R3TAS1R1KMT2AMEN1ALDH1A1
SCHEMBL92314 0.71 IDO1 (0.45) IDO1KMT2AMEN1GAAALDH1A1
SCHEMBL12019230 0.71 FFAR1 (0.61) IDO1KMT2AMEN1ALDH1A1POLB
SCHEMBL703278 0.71 TAS1R3 (1.00) TAS1R3TAS1R1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129086-B2 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-8129086-B2 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same PRRC2A, PUF60, POLR2B TAS1R3 1997/4885TAS1R1 1768/4885IDO1 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.